MEDIA | Cannabiz

Avecho’s deal with Sandoz was featured in Cannabiz, and an article by Steve Jones titled ‘Big pharma makes CBD over-the-counter move as Sandoz strikes 10-year deal with Avecho.‘

Here’s an excerpt:
“Pharmaceutical firm Sandoz has invested an initial A$4.8 million in Avecho’s attempt to register an over-the-counter CBD product after the two firms struck a 10-year development and licensing agreement.

“The investment is a leap of faith for the Switzerland-based pharma giant, with interim analysis of Avecho’s Phase III trial exploring CBD’s effect on insomnia still around 12-months away.

Read the full article.